Seeing straight with the help of artificial intelligence
The eye may be a window to the soul, but the retina is a window to health and wellness. A retinal test can help diagnose sight-threatening diseases, high blood pressure, heart disease, cancer, Alzheimer’s and other dangerous conditions.
AEYE Health, an Israeli startup with offices in Tel Aviv and New York, is on a mission to make early detection of those illnesses – starting with preventable blindness – as easy as taking a photograph.
One day in the not-too-distant future, screening for potential loss of sight “will be as easy as walking into a CVS, putting your chin on a chinrest, and learning within seconds if you’re at risk of going blind or not,” says Dr. Zack Dvey-Aharon, co-founder and CEO of AEYE. (The name sounds like “AI.”)
In the United States alone, some 35 million diabetics and 90 million prediabetics are at risk of developing diabetic retinopathy, the prime cause of blindness at working age. Another 55 million Americans aged 65 or older are at risk for glaucoma and age-related macular degeneration. Some 75 percent of the high-risk population does not undergo annual screening.